$THRX Pr on watch $16.25 FDA approves BREOÂ
Post# of 42
Posted On: 04/30/2015 5:32:05 PM
$THRX Pr on watch $16.25
FDA approves BREO® ELLIPTA®
(Partnered with Glaxo Group Limited (GSK))
for the treatment of adults with asthma in the US
Website
Shares Outstanding: 116.68M
Float: 62.08M
% Held by Insiders: 31.26%
% Held by Institutions: 80.80%
Shares Short (as of Mar 31, 2015): 25.53M
Short Ratio (as of Mar 31, 2015): 24.80
Short % of Float (as of Mar 31, 2015): 77.40%
Shares Short (prior month): 25.60M
Headlines
FDA approves BREO® ELLIPTA®
(Partnered with Glaxo Group Limited (GSK))
for the treatment of adults with asthma in the US
Website
Shares Outstanding: 116.68M
Float: 62.08M
% Held by Insiders: 31.26%
% Held by Institutions: 80.80%
Shares Short (as of Mar 31, 2015): 25.53M
Short Ratio (as of Mar 31, 2015): 24.80
Short % of Float (as of Mar 31, 2015): 77.40%
Shares Short (prior month): 25.60M
Headlines
(0)
(0)Innoviva, Inc. (INVA) Stock Research Links
Scroll down for more posts â–¼